Soligenix (SNGX) Competitors $3.56 +0.02 (+0.56%) (As of 11:46 AM ET) Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends SNGX vs. MITO, BLRX, PASG, LEXX, CLNN, PLUR, DYAI, DARE, ITRM, and MRKRShould you be buying Soligenix stock or one of its competitors? The main competitors of Soligenix include Stealth BioTherapeutics (MITO), BioLineRx (BLRX), Passage Bio (PASG), Lexaria Bioscience (LEXX), Clene (CLNN), Pluri (PLUR), Dyadic International (DYAI), Daré Bioscience (DARE), Iterum Therapeutics (ITRM), and Marker Therapeutics (MRKR). These companies are all part of the "medical" sector. Soligenix vs. Stealth BioTherapeutics BioLineRx Passage Bio Lexaria Bioscience Clene Pluri Dyadic International Daré Bioscience Iterum Therapeutics Marker Therapeutics Stealth BioTherapeutics (NASDAQ:MITO) and Soligenix (NASDAQ:SNGX) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their profitability, earnings, media sentiment, analyst recommendations, dividends, risk, institutional ownership, valuation and community ranking. Do insiders & institutionals believe in MITO or SNGX? 2.2% of Stealth BioTherapeutics shares are owned by institutional investors. Comparatively, 3.6% of Soligenix shares are owned by institutional investors. 2.8% of Soligenix shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth. Which has higher valuation & earnings, MITO or SNGX? Soligenix has lower revenue, but higher earnings than Stealth BioTherapeutics. Stealth BioTherapeutics is trading at a lower price-to-earnings ratio than Soligenix, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioStealth BioTherapeutics$21.09M1.12-$52.53M-$0.52-0.62Soligenix$840K10.64-$6.14M-$7.53-0.47 Does the media refer more to MITO or SNGX? In the previous week, Soligenix had 9 more articles in the media than Stealth BioTherapeutics. MarketBeat recorded 9 mentions for Soligenix and 0 mentions for Stealth BioTherapeutics. Soligenix's average media sentiment score of 0.43 beat Stealth BioTherapeutics' score of 0.00 indicating that Soligenix is being referred to more favorably in the news media. Company Overall Sentiment Stealth BioTherapeutics Neutral Soligenix Neutral Which has more volatility & risk, MITO or SNGX? Stealth BioTherapeutics has a beta of 1.46, indicating that its stock price is 46% more volatile than the S&P 500. Comparatively, Soligenix has a beta of 1.85, indicating that its stock price is 85% more volatile than the S&P 500. Does the MarketBeat Community prefer MITO or SNGX? Soligenix received 191 more outperform votes than Stealth BioTherapeutics when rated by MarketBeat users. Likewise, 72.97% of users gave Soligenix an outperform vote while only 63.50% of users gave Stealth BioTherapeutics an outperform vote. CompanyUnderperformOutperformStealth BioTherapeuticsOutperform Votes8763.50% Underperform Votes5036.50% SoligenixOutperform Votes27872.97% Underperform Votes10327.03% Is MITO or SNGX more profitable? Stealth BioTherapeutics has a net margin of 0.00% compared to Soligenix's net margin of -1,473.38%. Stealth BioTherapeutics' return on equity of 0.00% beat Soligenix's return on equity.Company Net Margins Return on Equity Return on Assets Stealth BioTherapeuticsN/A N/A -142.81% Soligenix -1,473.38%-223.29%-74.18% SummarySoligenix beats Stealth BioTherapeutics on 11 of the 15 factors compared between the two stocks. Ad Behind the Markets❗ RSVP please!Give us 60 minutes and we’ll show you how we’ve compressed 15 years of stock market gains into one day.Just click here and secure your spot! Get Soligenix News Delivered to You Automatically Sign up to receive the latest news and ratings for SNGX and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart SNGX vs. The Competition Export to ExcelMetricSoligenixPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$8.94M$6.32B$4.84B$8.73BDividend YieldN/A8.11%7.55%4.07%P/E Ratio-0.479.86120.1617.15Price / Sales10.64365.861,324.7790.61Price / CashN/A50.7536.9535.18Price / Book1.509.806.445.89Net Income-$6.14M$150.49M$113.90M$223.24M7 Day Performance-0.84%-5.05%0.34%0.60%1 Month Performance-8.01%-4.77%1.55%5.06%1 Year Performance-44.32%30.44%35.97%26.70% Soligenix Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)SNGXSoligenix1.0183 of 5 stars$3.56+0.6%N/A-45.2%$8.94M$840,000.00-0.4720MITOStealth BioTherapeuticsN/A$0.32flatN/AN/A$23.54M$21.09M-0.6229BLRXBioLineRx2.0583 of 5 stars$0.45+4.6%N/A-71.9%$36.29M$4.80M-1.0140Analyst ForecastGap UpPASGPassage Bio3.0464 of 5 stars$0.58-13.4%N/A-13.5%$35.95MN/A-0.43130Gap UpLEXXLexaria Bioscience2.3519 of 5 stars$2.26-1.7%N/A+53.4%$35.75M$230,000.00-5.147Upcoming EarningsCLNNClene3.2111 of 5 stars$4.82-9.1%N/A-50.1%$33.07M$650,000.00-1.08100Upcoming EarningsShort Interest ↑Analyst RevisionPLURPluri0.193 of 5 stars$6.04+9.2%N/A+11.7%$33.04M$330,000.00-1.00150Gap DownHigh Trading VolumeDYAIDyadic International2.5794 of 5 stars$1.12-1.8%N/A-33.9%$33.02M$2.90M-4.877Earnings ReportAnalyst RevisionNews CoverageGap UpDAREDaré Bioscience2.2738 of 5 stars$3.84-13.1%N/A-22.0%$32.79M$2.81M-3.4230Analyst ForecastGap DownHigh Trading VolumeITRMIterum Therapeutics2.1232 of 5 stars$1.43-3.4%N/A-14.9%$32.48MN/A-0.7210MRKRMarker Therapeutics3.9407 of 5 stars$3.64-2.2%N/A+7.7%$32.47M$3.31M0.0060Gap Up Related Companies and Tools Related Companies Stealth BioTherapeutics Competitors BioLineRx Competitors Passage Bio Competitors Lexaria Bioscience Competitors Clene Competitors Pluri Competitors Dyadic International Competitors Daré Bioscience Competitors Iterum Therapeutics Competitors Marker Therapeutics Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:SNGX) was last updated on 11/18/2024 by MarketBeat.com Staff From Our Partners5 Stocks that could triple in a week Robinhood traders have piled $78 billion into this market... Driving tiny tech stock gains of 3,000%, 8,942...Traders Agency | SponsoredTrump’s IRS Hands Massive ‘Victory Gift’ To 401K OwnersTrump quietly left open an "off the books" wealth-protection loophole hidden in the 6,871 pages of the IRS Tax...Colonial Metals | SponsoredFREE investing Class TOMORROW + 2 FREE BonusesOver the last 37 years on Wall Street, I've developed a unique investing strategy that allows me to find stock...Unstoppable Prosperity | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | SponsoredShocking footage from Bill Gates’ $100,000,000,000 AI BetIf you missed out on Nvidia, watch this video I just made.Brownstone Research | Sponsored🗓️ My First LIVE Event in 5 Years!Give us 60 minutes and we’ll show you how we’ve compressed 15 years of stock market gains into one day.Behind the Markets | SponsoredElon Musk’s $30 Billion Trump Bet Pays Off—What’s Next?Elon Musk bet big on Trump's victory, and that gamble has already added over $30 billion to his net worth in a...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Soligenix, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Soligenix With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
